BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21970911)

  • 1. Secondary prevention of fractures and compliance to treatment in osteoporosis.
    Trevisan C
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):22-4. PubMed ID: 21970911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture liaison service in a non-regional orthopaedic clinic--a cost-effective service.
    Ahmed M; Durcan L; O'Beirne J; Quinlan J; Pillay I
    Ir Med J; 2012 Jan; 105(1):24, 26-7. PubMed ID: 22397210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
    J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of osteoporosis: fracture risks, medication and treatment.
    Liu W; Yang LH; Kong XC; An LK; Wang R
    Minerva Med; 2015 Aug; 106(4):203-14. PubMed ID: 26125152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the orthopaedic in fragility fracture and in the prevention of a new fracture: SIOT 2009 recommendations.
    Tarantino U; Iundusi R; Cerocchi I; Liuni FM; Feola M; Celi M; Baldi J; Gasbarra E
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):25-7. PubMed ID: 21970912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of the patient with a high risk of fracture in clinical practice. Results from a survey of 174 Spanish Rheumatologists (OSTEOPAR project)].
    Casado E; Caamaño M; Sánchez-Bursón J; Salas E; Malouf J; Rentero ML; Herrero-Beaumont G
    Reumatol Clin; 2011; 7(5):305-13. PubMed ID: 21925446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing fracture risk with calcium and vitamin D.
    Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
    Talbot JC; Elener C; Praveen P; Shaw DL
    Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options in osteoporosis.
    Dominguez LJ; Scalisi R; Barbagallo M
    Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G; Demontiero O; Troen BR
    Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fighting the fracture cascade: evaluation and management of osteoporotic fractures.
    Sack F
    Postgrad Med; 2008 Nov; 120(4):51-7. PubMed ID: 19020365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of osteoporosis: room for improvment].
    Roux C
    Bull Acad Natl Med; 2010 Nov; 194(8):1483-8; discussion 1488-91. PubMed ID: 22046711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for treatment to prevent fragility fractures in postmenopausal women.
    Geusens P
    Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):727-40. PubMed ID: 19945685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.